title: Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.
abstract: Cardiorenal metabolic syndrome (CRS) is a global health care concern in view of aging in certain populations, increased obesity, changing lifestyles, and its close association with type 2 diabetes mellitus and cardiovascular morbidity and mortality. Determining the appropriate criteria for CRS has been somewhat controversial, and efforts to fully describe and define the syndrome are still ongoing. Nonetheless, improving knowledge of the syndrome among health care professionals will help to identify patients who may require pharmacological and therapeutic lifestyle intervention, particularly with regards to addressing high-normal blood pressure and hypertension. This article reviews current clinical guidelines with a focus on the identification, especially in racial/ethnic minorities, treatment, and associated cardiovascular morbidity and mortality of high blood pressure and hypertension in patients with CRS. Efficacy and outcomes studies that provide insight into the selection of an initial antihypertensive regimen in this population will be discussed. Finally, a brief review of the benefits of olmesartan medoxomil and combination therapy and patient factors in the management of hypertension with CRS will be addressed.
authors: Tulane School of Medicine, Tulane Heart and Vascular Institute, New Orleans, La., USA.
authors: Keith C
authors: KC
authors: Ferdinand
references: Hypertension. 2009 Apr;53(4):646-53
references: 19237683
references: Endocr Rev. 2008 Dec;29(7):777-822
references: 18971485
references: Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):153-62
references: 22396585
references: Lancet. 2002 Mar 23;359(9311):995-1003
references: 11937178
references: JAMA. 2002 Dec 18;288(23):2981-97
references: 12479763
references: Diabetes Care. 2008 Feb;31(2):353-60
references: 18000186
references: Am J Med. 2007 Aug;120(8):713-9
references: 17679131
references: Metab Syndr Relat Disord. 2012 Apr;10(2):77-82
references: 22224930
references: Arch Intern Med. 1997 Nov 24;157(21):2413-46
references: 9385294
references: Circulation. 2005 Oct 25;112(17):2735-52
references: 16157765
references: Arch Intern Med. 2005 Oct 10;165(18):2098-104
references: 16216999
references: Eur Heart J. 2012 Jul;33(13):1635-701
references: 22555213
references: Circulation. 2002 Dec 17;106(25):3143-421
references: 12485966
references: N Engl J Med. 2010 Apr 29;362(17):1575-85
references: 20228401
references: Am J Med. 2009 Mar;122(3):290-300
references: 19272490
references: MMWR Morb Mortal Wkly Rep. 2007 Mar 2;56(8):161-5
references: 17332726
references: Am J Cardiol. 2011 May 1;107(9):1346-52
references: 21497211
references: Circulation. 2012 Jan 3;125(1):e2-e220
references: 22179539
references: J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
references: 20863953
references: Kidney Int. 2012 Mar;81(6):568-76
references: 22189843
references: Lancet. 2005 Sep 24-30;366(9491):1059-62
references: 16182882
references: JAMA. 2002 Jan 16;287(3):356-9
references: 11790215
references: J Hypertens. 2007 Jun;25(6):1105-87
references: 17563527
references: Circulation. 2009 Oct 20;120(16):1640-5
references: 19805654
references: Circulation. 1994 Sep;90(3):1185-93
references: 8087927
references: Ir J Med Sci. 2009 Jun;178(2):161-6
references: 19129978
references: J Am Coll Cardiol. 2005 Sep 6;46(5):821-6
references: 16139131
references: Natl Health Stat Report. 2009 May 5;(13):1-7
references: 19634296
references: Heart Rhythm. 2012 Apr;9(4):531-7
references: 22079554
references: Lancet. 2005 Sep 10-16;366(9489):895-906
references: 16154016
references: Diabetes Care. 2003 Mar;26(3):575-81
references: 12610004
references: Lancet. 2002 Dec 14;360(9349):1903-13
references: 12493255
references: Cardiovasc Diabetol. 2008 Dec 12;7:35
references: 19077281
references: JAMA. 2010 May 26;303(20):2043-50
references: 20501926
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199
references: Ethn Dis. 2006 Autumn;16(4):830-6
references: 17061734
references: J Hypertens. 2010 May;28(5):999-1006
references: 20308922
references: Hypertension. 2010 Nov;56(5):780-800
references: 20921433
references: J Clin Hypertens (Greenwich). 2011 Jun;13(6):404-12
references: 21649839
references: Am J Cardiol. 2007 Jun 18;99(12A):44i-55i
references: 17599425
references: N Engl J Med. 2006 Apr 20;354(16):1685-97
references: 16537662
references: Cardiorenal Med. 2011;1(1):5-12
references: 22258461
references: Diab Vasc Dis Res. 2007 Dec;4(4):365-7
references: 18158709
references: Diabet Med. 1998 Jul;15(7):539-53
references: 9686693
references: JAMA. 2000 Apr 19;283(15):1967-75
references: 10789664
references: Curr Cardiovasc Risk Rep. 2009 Jan 1;3(3):161-167
references: 22368728
references: J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
references: 12461301
references: N Engl J Med. 2010 Sep 2;363(10):918-29
references: 20818902
references: Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
references: 22187469
references: Arch Intern Med. 2003 Feb 24;163(4):427-36
references: 12588201
references: N Engl J Med. 2008 Dec 4;359(23):2417-28
references: 19052124